COMP <GO>
KNSA vs UNH // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Kiniksa Pharmaceuticals International plc (Class A) (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: KNSA 8
— UNH 6
■ METRIC PARITY
LAST: $90.80 (-1.56%) • MKT CAP: $7.13B
options-implied-move
—
LAST: $400.44 (-1.60%) • MKT CAP: $359.43B
options-implied-move
7.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (KNSA VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | KNSA | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 88.50% | 88.31% | +0.19 | KNSA | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.90% | 12.38% | -2.48 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | 95.0x | 15.3x | +79.73 | UNH | /valuation <GO> |
| Free Cash Flow Yield | 1.78% | 6.25% | -4.47 | UNH | /fcf-yield <GO> |
| Operating Margin | 11.40% | 5.32% | +6.08 | KNSA | /operating-margins <GO> |
| Net Profit Margin | 8.70% | 3.53% | +5.17 | KNSA | /net-margins <GO> |
| Revenue Growth (YoY) | 60.10% | 3.33% | +56.77 | KNSA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.29% | -2.29 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 24.45 | 3.09 | +21.36 | KNSA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 7/9 | +2.00 | KNSA | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | 7.00% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 57.2 | 55.1 | +2.10 | KNSA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.11 | 0.33 | +0.78 | KNSA | /macro-sensitivity <GO> |
| Forward P/E Multiple | 109.1x | 17.7x | +91.36 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $7.13B | $359.43B | -$352.30B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | KNSA REV | UNH REV | KNSA GROSS % | UNH GROSS % | KNSA FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $677.6M | $447.57B | 88.5% | 88.7% | $136.4M | $16.07B |
| FY 2024 | $423.2M | $400.28B | 85.6% | 88.3% | $25.4M | $20.70B |
| FY 2023 | $270.3M | $371.62B | — | 89.6% | $1.1M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
KNSA // BETA 1.11
UNH // BETA 0.33